Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Tobacco Use Disorder 5Smoking Cessation 5Smoking 4Lung Neoplasms 4Uterine Cervical Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tobacco Use 2Small Cell Lung Carcinoma 2Head and Neck Neoplasms 2Cigarette Smoking 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Tobacco Use Cessation 1Tobacco Smoking 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Tobacco Use Cessation Devices × Clear all
NCT01434342 2021-09-28

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Completed
146 enrolled 10 charts
BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Tobacco Use Disorder, Colorectal Neoplasms

NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Vanderbilt University Medical Center

Phase 2 Completed
22 enrolled 14 charts
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡